-
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. EMCURE PHARMACEUTICALS LIMITED et al DC CAFC
- 2:15-cv-00280
- D.N.J.
- Judge: Stanley R. Chesler
+1
- Filed: 01/14/2015
- Closed: 02/28/2017
- Latest Docket Entry: 05/22/2018
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
777
Days in
Litigation
-
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. EMCURE PHARMACEUTICALS LIMITED et al DC CAFC
- 2:15-cv-00280
- D.N.J.
- Judge: Stanley R. Chesler
+1
- Filed: 01/14/2015
- Closed: 02/28/2017
- Latest Docket Entry: 05/22/2018
- PACER
- Docket updated daily
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
-
Infringement
Emcure Pharmaceuticals Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 20 mg, 40 mg, 60 mg, 80 mg generic lurasidone hydrochloride tablets | US 5,532,372 A |
14
|
Infringement
Entry 138
|
Emcure Pharmaceuticals USA, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 20 mg, 40 mg, 60 mg, 80 mg generic lurasidone hydrochloride tablets | US 5,532,372 A |
14
|
Infringement
Entry 138
|
Invagen Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic 20 mg, 40 mg, 60 mg, 80 mg, 120 mg hydrochloride tablets | US 5,532,372 A |
14
|
Infringement
Entry 141
|
